{
  "trial_id": "NCT01524991",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Histological or cytological proof of urothelial carcinoma",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age > 18 years at the time of consent",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Written informed consent and HIPAA authorization for release of personal health information",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Prior Autoimmune disease: Patients with a history of inflammatory bowel disease, including ulcerative colitis and Crohn's Disease",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "No active CNS metastases. Subjects with neurological symptoms must undergo a head CT scan or brain MRI to exclude brain metastasis.",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient has lower urinary tract symptoms and IPSS score of 15, but no history of autoimmune disease or active CNS metastases.",
  "_meta": {
    "topic_id": "24",
    "trial_id": "NCT01524991",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}